9th India Medical Device 2026 opens in New Delhi to focus on developing India as global MedTech hub

image credit- pib

The 9th edition of the two-day India Medical Device 2026 began on 7th August at Vigyan Bhawan, New Delhi. The conference is bringing together policymakers, regulators, industrialists, innovators, and other stakeholders to advance the country's medical devices sector and strengthen its position as a global hub for quality medical devices.

The conference is being organised by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICC) on the theme "Towards Viksit Bharat: India's Progress as a Global Hub for Quality Medical Devices".

Manoj Joshi, Secretary, Department of Pharmaceuticals, while addressing the inaugural session, emphasised that the medical devices sector should be viewed from both the healthcare and industry perspectives.

The Secretary said that we have to create an export-oriented industry that can cater to the needs of global markets. The Indian medical devices market is valued at around $16 billion, while the global market is valued at over $600 billion, offering immense opportunities for Indian manufacturers. 

Dr Rajiv Singh Raghuvanshi, Drug Controller General of India (DCGI), said that India's medical devices sector is undergoing a fundamental transition from an import-based market to a domestic manufacturing-based ecosystem. He stressed on the need to strengthen indigenous capabilities in high-end Class C and Class D medical devices and in vitro diagnostics, while ensuring prompt, transparent and predictive regulatory approvals.

The next phase of growth is to foster India's innovation, strengthen R&D, build resilient supply chains, develop advanced manufacturing capabilities, promote globally harmonised quality standards, said Jyoti Vij, Director General, FICCI.